Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Biological Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11278442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous patterns of TGFbeta superfamily signaling during early Xenopus development.

  2000cited by this paper
• Betaglycan binds inhibin and can mediate functional antagonism of activin signalling

  2000cited by this paper
• Cell Surface Heparan Sulfate Proteoglycans: Selective Regulators of Ligand-Receptor Encounters*

  2000cited by this paper
• Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart.

  1999cited by this paper
• Specificity, diversity, and regulation in TGF-beta superfamily signaling.

  1999cited by this paper
• Murine betaglycan primary structure, expression and glycosaminoglycan attachment sites.

  1998cited by this paper
• Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2*

  1998cited by this paper
• Expression of transforming growth factor beta (TGFbeta) type III receptor restores autocrine TGFbeta1 activity in human breast cancer MCF-7 cells.

  1997cited by this paper
• Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and Is Required for Transforming Growth Factor-β Signaling*

  1997cited by this paper
• TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling*

  1997cited by this paper
• Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells.

  1997cited by this paper
• Activation of signalling by the activin receptor complex

  1996cited by this paper
• Betaglycan has multiple binding sites for transforming growth factor-beta 1.

  1996cited by this paper
• Tissue-specific binding of radiolabeled activin A by activin receptors and follistatin in postimplantation rat and mouse embryos.

  1996cited by this paper
• Expression of Transforming Growth Factor Type III Receptor in Vascular Endothelial Cells Increases Their Responsiveness to Transforming Growth Factor β2 (*)

  1995cited by this paper
• Mutagenesis analysis of the membrane‐proximal ligand binding site of the TGF‐β receptor type III extracellular domain

  1995cited by this paper
• Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites

  1994cited by this paper
• TGF-beta receptors and actions.

  1994cited by this paper
• The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.

  1994cited by this paper
• Mapping of the ligand binding domain of the transforming growth factor beta receptor type III by deletion mutagenesis.

  1994cited by this paper
• Betaglycan presents ligand to the TGF beta signaling receptor.

  1993cited by this paper
• Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

  1993cited by this paper
• The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand.

  1993cited by this paper
• Functional expression and growth factor activation of an epitope-tagged p44 mitogen-activated protein kinase, p44mapk.

  1992cited by this paper
• Binding of two growth factor families to separate domains of the proteoglycan betaglycan.

  1992cited by this paper
• Subtypes of betaglycan and of type I and type II transforming growth factor-beta (TGF-beta) receptors with different affinities for TGF-beta 1 and TGF-beta 2 are exhibited by human placental trophoblast cells.

  1992cited by this paper
• A large domain common to sperm receptors (Zp2 and Zp3) and TGF-beta type III receptor.

  1992cited by this paper
• Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.

  1992cited by this paper
• Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system.

  1991cited by this paper
• Purification of the transforming growth factor-beta (TGF-beta) binding proteoglycan betaglycan.

  1991cited by this paper
• Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

  1991cited by this paper
• Expression cloning and characterization of the TGF-beta type III receptor.

  1991cited by this paper
• Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms.

  1990cited by this paper
• Transforming growth factor-beta (TGF-beta) receptor proteoglycan. Cell surface expression and ligand binding in the absence of glycosaminoglycan chains.

  1989cited by this paper
• Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta

  1989cited by this paper
• Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme.

  1989cited by this paper
• The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor.

  1988cited by this paper
• Membrane binding characteristics of two forms of transforming growth factor-beta.

  1987cited by this paper
• Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure.

  1987cited by this paper
• Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

  1985cited by this paper

• Structures of TGF-β with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling

  2025cites this paper
• Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer

  2024influential citation
• Single-Cell RNA Sequencing Reveals Cardiac Fibroblast-Specific Transcriptomic Changes in Dilated Cardiomyopathy

  2024cites this paper
• TGF-β signaling in health, disease and therapeutics

  2024cites this paper
• Development of Liver-Targeting αVβ5+ Exosomes as Anti-TGF-β Nanocarriers for the Treatment of the Pre-Metastatic Niche

  2024cites this paper
• Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signaling

  2023cites this paper
• Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β co-receptor betaglycan

  2022cites this paper
• TGF‐β superfamily co‐receptors in cancer

  2021cites this paper
• Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis

  2021cites this paper
• Chordacentrum mineralization is delayed in zebrafish betaglycan‐null mutants

  2021cites this paper
• TGFBR3L is an inhibin B co-receptor that regulates female fertility

  2021cites this paper
• Endoglin Level Is Critical for Cartilage Tissue Formation In Vitro by Passaged Human Chondrocytes

  2020cites this paper
• A Tale of Two Proteins: Betaglycan, IGSF1, and the Continuing Search for the Inhibin B Receptor.

  2020cites this paper
• A novel exopolysaccharide from marine bacterium Pantoea sp. YU16-S3 accelerates cutaneous wound healing through Wnt/β-catenin pathway.

  2020cites this paper
• The Role of TGFβ in Clinical Cancer Response

  2020cites this paper
• Novel venom-based peptides (P13 and its derivative—M6) to maintain self-renewal of human embryonic stem cells by activating FGF and TGFβ signaling pathways

  2020cites this paper
• Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer

  2020cites this paper
• Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions

  2020cites this paper
• Structural Adaptation in Its Orphan Domain Engenders Betaglycan with an Alternate Mode of Growth Factor Binding Relative to Endoglin.

  2019cites this paper
• Betaglycan (TβRIII) is a Key Factor in TGF-β2 Signaling in Prepubertal Rat Sertoli Cells

  2019cites this paper
• Structural biology of betaglycan and endoglin, membrane-bound co-receptors of the TGF-beta family

  2019cites this paper
• Endoglin Trafficking/Exosomal Targeting in Liver Cells Depends on N-Glycosylation

  2019cites this paper
• TGF-&bgr; family co-receptor function and signaling

  2018cites this paper
• Transforming growth factor-β in stem cells and tissue homeostasis

  2018cites this paper
• Betaglycan (TGFBR3) Functions as an Inhibin A, but Not Inhibin B, Coreceptor in Pituitary Gonadotrope Cells in Mice.

  2018cites this paper
• TGF-β2 uses the concave surface of its extended finger region to bind betaglycan's ZP domain via three residues specific to TGF-β and inhibin-α

  2018cites this paper
• Dually modified transmembrane proteoglycans in development and disease.

  2017cites this paper
• TβRIII is induced by TCR signaling and downregulated in FoxP3+ regulatory T cells.

  2017cites this paper
• A Selective Transforming Growth Factor- b Ligand Trap Attenuates Pulmonary Hypertension

  2016cites this paper
• Determination of the substrate repertoire of ADAMTS2, 3, and 14 significantly broadens their functions and identifies extracellular matrix organization and TGF‐β signaling as primary targets

  2016influential citation
• Structural Biology and Evolution of the TGF-β Family.

  2016cites this paper
• Binding Properties of the Transforming Growth Factor-β Coreceptor Betaglycan: Proposed Mechanism for Potentiation of Receptor Complex Assembly and Signaling

  2016cites this paper
• Targeting of Proteoglycan Synthesis Pathway: A New Strategy to Counteract Excessive Matrix Proteoglycan Deposition and Transforming Growth Factor-β1-Induced Fibrotic Phenotype in Lung Fibroblasts

  2016cites this paper
• Regulation of TGFβ/Smad signalling during early follicle development in the mouse ovary

  2016cites this paper
• Significance of TGFBR3 allelic loss in the deregulation of TGFβ signaling in primary human endometrial carcinomas.

  2016cites this paper
• Betaglycan knock‐down causes embryonic angiogenesis defects in zebrafish

  2015cites this paper
• The role of GDF5 in the developing vertebrate nervous system

  2015cites this paper
• Simvastatin alleviates cardiac fibrosis induced by infarction via up‐regulation of TGF‐β receptor III expression

  2015cites this paper
• Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer

  2014cites this paper
• Functional role of TGF-β receptors during palatal fusion in vitro.

  2014cites this paper
• Proteolytic control of TGF-β co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics

  2014cites this paper
• A Synthetic Peptide from Transforming Growth Factor-β1 Type III Receptor Inhibits NADPH Oxidase and Prevents Oxidative Stress in the Kidney of Spontaneously Hypertensive Rats

  2013cites this paper
• Identification of a Novel TGF-β-Binding Site in the Zona Pellucida C-terminal (ZP-C) Domain of TGF-β-Receptor-3 (TGFR-3)

  2013cites this paper
• Transforming growth factor β1 (TGFβ1) in physiology and pathology.

  2013cites this paper
• Regulation der TGFβ Signaltransduktion durch Phosphorylierung des Transkriptions-Cofaktors Smif

  2013cites this paper
• Ectodomain Shedding of TGF-beta Receptors: Role in Signaling and Breast Cancer Biology

  2013cites this paper
• Role of proteoglycans in the regulation of the skeletal muscle fibrotic response

  2013cites this paper
• TGF-β-activated kinase-1: New insights into the mechanism of TGF-β signaling and kidney disease

  2012cites this paper
• TGF-β – an excellent servant but a bad master

  2012cites this paper
• Blockade of TGF-β 1 Signalling Inhibits Cardiac NADPH Oxidase Overactivity in Hypertensive Rats

  2012cites this paper
• Regulation of TGF-β receptor activity

  2012cites this paper
• Functional Overlap Between Chondroitin and Heparan Sulfate Proteoglycans During VEGF-Induced Sprouting Angiogenesis

  2012cites this paper
• Betaglycan (TβRIII) Is Expressed in the Thymus and Regulates T Cell Development by Protecting Thymocytes from Apoptosis

  2012cites this paper
• The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis

  2012cites this paper
• Reprint of: Betaglycan: A multifunctional accessory

  2012influential citation
• New insights into the mechanisms of activin action and inhibition.

  2012cites this paper
• Haplotype and mutation analysis of the TGFBR3 gene in Chinese women with idiopathic premature ovarian failure

  2012cites this paper
• Transforming growth factor β signaling perturbation in the Loeys-Dietz syndrome.

  2012cites this paper
• TGFBR3 (transforming growth factor, beta receptor III)

  2011cites this paper
• Identification of novel missense mutations of the TGFBR3 gene in Chinese women with premature ovarian failure.

  2011cites this paper
• Betaglycan Is Required for the Establishment of Nephron Endowment in the Mouse

  2011cites this paper
• Structure of betaglycan zona pellucida (ZP)-C domain provides insights into ZP-mediated protein polymerization and TGF-β binding

  2011influential citation
• Betaglycan: a multifunctional accessory.

  2011cites this paper
• Structures of TGF-β receptor complexes: implications for function and therapeutic intervention using ligand traps.

  2011cites this paper
• A Structural View of Egg Coat Architecture and Function in Fertilization1

  2011cites this paper
• TGF-β and its coreceptors in cancerogenesis: an overview.

  2011cites this paper
• Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.

  2011cites this paper
• The type III TGF-β receptor betaglycan transmembrane-cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease γ-secretase.

  2011cites this paper
• plasticity of TGF-β signaling

  2011cites this paper
• Bone turnover across the menopause transition

  2010cites this paper
• Roles for the type III TGF-beta receptor in human cancer.

  2010cites this paper
• Inhibin and premature ovarian failure.

  2010cites this paper
• TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy

  2010cites this paper
• The Role of the TGF-β Coreceptor Endoglin in Cancer

  2010cites this paper
• Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor.

  2009cites this paper
• Transforming growth factor β1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance

  2009cites this paper
• Immunoneutralization of TGFβ1 Improves Skeletal Muscle Regeneration: Effects on Myoblast Differentiation and Glycosaminoglycan Content

  2009cites this paper
• The emerging role of TGF-beta superfamily coreceptors in cancer.

  2009cites this paper
• Reducing betaglycan expression by RNA interference (RNAi) attenuates inhibin bioactivity in LbetaT2 gonadotropes.

  2009cites this paper
• Analysis of activin/TGFB-signaling modulators within the normal and dysfunctional adult human testis reveals evidence of altered signaling capacity in a subset of seminomas.

  2009cites this paper
• The search for Nkx2-5-regulated genes using purified embryonic stem cell-derived cardiomyocytes with Nkx2-5 gene targeting.

  2009cites this paper
• Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin.

  2009cites this paper
• Identification of differentially expressed genes in trabecular bone from the iliac crest of osteoarthritic patients.

  2009cites this paper
• Association of tetraspanin CD9 with transmembrane TGFα confers alterations in cell-surface presentation of TGFα and cytoskeletal organization

  2008cites this paper
• Suppression of Inhibin A Biological Activity by Alterations in the Binding Site for Betaglycan*

  2008cites this paper
• Inhibin and the regulation of bone mass

  2008cites this paper
• A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats.

  2008cites this paper
• Bone Morphogenetic Proteins Signal through the Transforming Growth Factor-β Type III Receptor*

  2008cites this paper
• Astrocytes in glaucomatous optic neuropathy.

  2008cites this paper
• Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.

  2008cites this paper
• Selection of mutant CHO clones resistant to murine gammaherpesvirus 68 infection.

  2008cites this paper
• Expression, purification and characterization of BG(E)RII: a novel pan-TGFbeta inhibitor.

  2008cites this paper
• Endocytosis of the Type III Transforming Growth Factor-β (TGF-β) Receptor through the Clathrin-independent/Lipid Raft Pathway Regulates TGF-β Signaling and Receptor Down-regulation*

  2008cites this paper
• TGFβ1 expression in colonic mucosa: modulation by dietary lipids

  2007cites this paper
• Co-Expression of the TGF-b 1 and TGF-b 2 Isoforms in Nasal Polyps and in Healthy Mucosa

  2007cites this paper
• [The profile of expression of transforming growth factor beta1 and TGFbetaRI, TGFbetaRII and TGFbetaRIII genes in nasal polyps].

  2007cites this paper
• Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.

  2007cites this paper
• The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation.

  2007cites this paper
• Mutational analysis of betaglycan/TGF-betaRIII in premature ovarian failure.

  2007cites this paper
• Inhibitors of the TGF-beta superfamily and their clinical applications.

  2006cites this paper